publication date: Aug. 1, 2014

Ethicon, the Johnson & Johnson subsidiary that manufactures nearly three-quarters of laparoscopic power morcellators on the market, has requested a withdrawal of the controversial devices.

“Immediately review inventory to determine if you have any Ethicon Morcellation Devices which are the subject of this market withdrawal,” the company wrote in a letter to hospitals worldwide.

“If you have provided Ethicon Morcellation Devices to any hospital within your system, you are responsible for notifying the appropriate parties immediately,” said the letter dated July 31.

Ethicon said it will reimburse customers for all devices returned by Dec. 30, 2014.

The company’s decision to pull the devices off the market comes as a result of a series of extraordinary events:

Eight months ago, two Harvard physicians launched a high-profile campaign against power morcellation (The Cancer Letter, July 4). Three months ago, FDA issued in an advisory on power morcellation, a move that was soon followed by Ethicon’s decision to suspend global sales of the devices. Continue reading 40-31 J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.